21 February 2014
- Medicines

Rationale: 12 patient experts from EFA member associations will have the opportunity to discover what the European Medicines Agency (EMA) is and especially how patients can be involved in its activities. Through EFA, patient experts on allergy, asthma and COPD across Europe can be involved in the important work that EMA is doing throughout the process of evaluating and communicating about medicines. This will be the first training of this type organised by EFA, and therefore it will be addressed to beginners.EFA members will learn from the patient experts already involved with EMA, as well as from EMA secretariat itself.

Learning objectives: After completion of the training, EFA members will be empowered to understand the role of the EMA, role of patients at the EMA, manage administrative issues and understand conflict of interest issues linked to being involved in EMA activities (e.g.: meetings, review of documents) and be empowered to effectively and proactively participate.

The event is for EFA members only.

For more information, please contact This email address is being protected from spambots. You need JavaScript enabled to view it.

The programme of the event is available here

EFA report on patients involvement with EMA

Dear Visitor,

for regularly updated information on Covid-19 for allergy and respiratory patients, please consult our Covid-19 resource and information hub.
Stay safe!
The EFA Team